explore -WSS

explore

author：leisure time 2025-08-11 08:00:07 - browse：1

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： President Biden's budget: Here's what you might have missed

explore

WSS

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

ProMED sees offers of support, but its future remains unclear

Living with Hashimoto's and celiac disease, and med school, too

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Amid AI frenzy, a top HHS official's quest to create safeguards

Why scientists need input from humanists on sensitive research

hotspot

explore

Gilead needs Arcellx more than ever

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Boston's new lab space is opening empty

Trump demands the U.S. pay no more for drugs than other countries … again

UCLA team creates talking throat patch for voice disorders

Dobbs anniversary: the lost opportunity of abortion as health care

Why depression after traumatic brain injury is distinct

Guidelines to prevent youth baseball injuries need more muscle

WuXi out of biotech trade group, U.S. and China relations to blame

Tori Bowie and the unacceptable rates of Black maternal death

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

hotspot

Amid AI frenzy, a top HHS official's quest to create safeguards

Baltimore teen accused of firing into crowd during block party mass shooting

John Green on his newest strategy for fighting tuberculosis

Evacuations in place as 3 wildfires burn in eastern Washington state

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

hotspot

knowledge

explore

Wikipedia